Myriad Genetics Inc (MYGN)
17.60
-0.24
(-1.32%)
USD |
NASDAQ |
Nov 05, 16:00
17.50
-0.10
(-0.54%)
After-Hours: 18:47
Myriad Genetics Shareholders Equity (Quarterly): 740.50M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 740.50M |
March 31, 2024 | 760.00M |
December 31, 2023 | 783.20M |
September 30, 2023 | 683.40M |
June 30, 2023 | 735.20M |
March 31, 2023 | 835.20M |
December 31, 2022 | 885.80M |
September 30, 2022 | 916.60M |
June 30, 2022 | 947.40M |
March 31, 2022 | 950.10M |
December 31, 2021 | 967.80M |
September 30, 2021 | 968.60M |
June 30, 2021 | 902.50M |
March 31, 2021 | 875.20M |
September 30, 2020 | 909.30M |
June 30, 2020 | 918.20M |
March 31, 2020 | 967.20M |
December 31, 2019 | 1.077B |
September 30, 2019 | 1.074B |
June 30, 2019 | 1.089B |
March 31, 2019 | 1.082B |
December 31, 2018 | 1.064B |
September 30, 2018 | 1.102B |
June 30, 2018 | 966.10M |
March 31, 2018 | 948.30M |
Date | Value |
---|---|
December 31, 2017 | 914.20M |
September 30, 2017 | 870.90M |
June 30, 2017 | 768.40M |
March 31, 2017 | 748.20M |
December 31, 2016 | 732.90M |
September 30, 2016 | 735.50M |
June 30, 2016 | 748.10M |
March 31, 2016 | 770.20M |
December 31, 2015 | 770.80M |
September 30, 2015 | 687.10M |
June 30, 2015 | 662.10M |
March 31, 2015 | 668.90M |
December 31, 2014 | 694.24M |
September 30, 2014 | 712.15M |
June 30, 2014 | 719.00M |
March 31, 2014 | 722.24M |
December 31, 2013 | 675.97M |
September 30, 2013 | 690.27M |
June 30, 2013 | 728.59M |
March 31, 2013 | 664.93M |
December 31, 2012 | 662.12M |
September 30, 2012 | 635.57M |
June 30, 2012 | 635.66M |
March 31, 2012 | 652.19M |
December 31, 2011 | 616.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
683.40M
Minimum
Sep 2023
1.077B
Maximum
Dec 2019
879.08M
Average
905.90M
Median
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Abbott Laboratories | 39.80B |
Personalis Inc | 112.27M |
Perspective Therapeutics Inc | 341.00M |
Electromed Inc | 44.54M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.085B |
Total Liabilities (Quarterly) | 344.60M |
Debt to Equity Ratio | 0.0524 |
Current Ratio | 1.958 |
Net Debt Paydown Yield | -0.35% |